Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This randomized phase III trial is comparing two different combination chemotherapy regimens to see how well each works in treating patients with previously untreated rhabdomyosarcoma or sarcoma. Drugs used in chemotherapy, such as dactinomycin, cyclophosphamide, vincristine, and topotecan, use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective in treating rhabdomyosarcoma.
Epistemonikos ID: 28ed5dd3c36d7c8953fe14af47de485632b79ff9
First added on: May 03, 2024